A acute coronary acute coronary syndrome-2-Coronary artery injury and the biology of atherosclerosis-inflammation, thrombosis, and stabilization acute coronary syndrome-2Exploring new strategies for the management of acute coronary syndromes acute coronary syndrome-2-Introduction clin chem-Preoperative Serum Prostate-specific Antigen (PSA) Below 10 μg-L-Prostate Cancer acute coronary syndrome-2Medical therapy of unstable angina and non_q-wave myocardial infarction acute coronary syndrome-2-Relation between endothelial dysfunction and the acute coronary syndrome-implications for therapy acute coronary syndrome-2-Role of plaque rupture in acute coronary syndromes acute coronary syndrome-2Should intensive cholesterol lowering play a role in the management of acute coronary syndromes acute coronary syndrome-2-The new directions in the understanding and management of acute coronary syndromes acute coronary syndrome-Acute statin treatment in reducing risk after acute coronary syndrome acute coronary syndromes-Aborted sudden cardiac death acute coronary syndromes-An ischemia-guided approach for risk stratification in patients Acute Coronary Syndromes-Antithrombotic Therapy in Patients With Acute Coronary Syndromes Acute Coronary Syndromes-Antithrombotic Therapy in Patients With Acute Coronary Syndromes-1 acute coronary syndromes-Avoidance of routine revascularization in the management of patients with non-ST-segment elevation acute coronary syndromes-Calming the plaque to delay intervention for 24 hours acute coronary syndromes-Defining the optimal pharmacotherapy of non–ST-segment elevation (NSTE) acute coronary syndromes (ACS) acute coronary syndromes-Defining the role of abciximab for acute coronary syndromes acute coronary syndromes-extending medical intervention for five days before proceeding to revascularization acute coronary syndromes-Guidelines for acute coronary syndromes acute coronary syndromes-Inflammatory role of platelets in acute coronary syndromes acute coronary syndromes-Introduction_Evidence to Practice in Acute Coronary Syndromes Acute Coronary Syndromes-Low-Molecular-Weight Heparins in the Treatment of Acute Coronary Syndromes Acute Coronary Syndromes-Management of Acute Coronary Syndromes acute coronary syndromes-New advances in the management of acute coronary syndromes 2. Fibrinolytic therapy for acute ST-segment elevation myocardial infarction acute coronary syndromes-New advances in the management of acute coronary syndromes-2 acute coronary syndromes-New advances in the management of acute coronary syndromes-3. The role of catheter-based procedures acute coronary syndromes-Small peptide GP IIb-IIIa receptor inhibitors as upstream therapy in acute coronary syndromes acute coronary syndromes-Strategies of patient care acute coronary syndromes-Sudden cardiac death- acute coronary syndromes-The role of low-molecular-weight heparin in the management of acute coronary syndromes acute coronary syndromes-Therapeutic adjuncts for immediate transfer to the catheterization laboratory acute coronary syndromes-Thrombosis prophylaxis in the acutely ill medical patient Adrenomedullin and proadrenomedullin N-terminal 20 peptide Adrenomedullin, a Multifunctional Regulatory Peptide Angiogenesis Angiogenesis and Bone Growth Angiogenesis in hematologic malignancies angiogenesis-Potentials for Pharmacologic Intervention in the Treatment of Cancer, Cardiovascular Diseases, and Chronic Inflammation Angiogenesis-Angiomotin Regulates Endothelial Cell Motility Angiogenesis-Antibody-Based Targeting of Angiogenesis angiogenesis-Arteriogenesis Versus Angiogenesis-Two Mechanisms of Vessel Growth angiogenesis-ck-Signaling properties of VEGF receptor-1 and-2 homo-and heterodimers angiogenesis-ephrins and Eph receptors in angiogenesis angiogenesis-Functionally Active VEGF Fusion Proteins angiogenesis-Human endothelial gelatinases and angiogenesis Angiogenesis-Inhibition of Glioma Angiogenesis and Growth in Vivo by Systemic Treatment with a Monoclonal Antibody against Vascular Endothelial Growth Factor Receptor-2 Angiogenesis-Integrating the VEGF Signals Leading to Actin-Based Motility in Vascular Endothelial Cells angiogenesis-l-In Vitro Models of Vasculogenesis and Angiogenesis angiogenesis-Regulation of angiogenesis in the endometrium angiogenesis-Revascularization for cardiogenic shock angiogenesis-revascularization-Cholesterol lowering in atherosclerosis angiogenesis-revascularization-Foreword angiogenesis-revascularization-Introduction- angiogenesis-revascularization-Introduction-comparative pathobiology of atherosclerosis and restenosis angiogenesis-revascularization-Introduction-Interventions in cardiology-what does and does not work angiogenesis-revascularization-Lipid-lowering therapy after coronary revascularization angiogenesis-revascularization-Rationale for a postintervention continuum of care-insights from intravascular ultrasound Angiogenesis-Role of Id Proteins in Embryonic and Tumor Angiogenesis Angiogenesis-The Neuropilins-Multifunctional Semaphorin and VEGF Receptors that Modulate Axon Guidance and Angiogenesis angiogensis--treatment of spontaneous carotid and vertebral artery dissections angiogensis-ephrins and Eph receptors in angiogenesis angiogensis-Pulmonary complications after coronary revascularization angiogensis-Signal transduction by VEGF receptor-1 wild type and mutant Angiogenesis-The Neuropilins-Multifunctional Semaphorin and VEGF Receptors that Modulate Axon Guidance and Angiogenesis Another-view of myocardial hibernation another-Arterial calcification aother-Arterial calcification-A review of mechanisms, animal models, and the prospects for therapy aother-Brugada syndrome-diagnostic criteria and cellular mechanisms aother-Chest pain-a historical perspective aother-Clinical developments in cardiac activation mapping aother-Digital Echocardiography-Its Role in Modern Medical Practice aother-Echocardiographic-Echocardiographic evaluation of mitral regurgitation aother-Echocardiographic-Echocardiographic assessment of diastolic function aother-Echocardiographic-Recent advances in myocardial contrast echocardiography aother-Rapid cardiology—for chest pain, breathlessness and palpitations aother-Recognising painless heart attacks aother-Sleep Apnea and Cardiovascular Disease aother-Snoring, sleep apnoea and stroke aother-The European Society of Cardiology into the next decade aother-The significance of heartburn arrhythmia-ACE inhibitors or angiotensin II antagonists reduce total mortality and arrhythmic mortality arrhythmia-Advances in implantable cardioverter defibrillators arrhythmia-Algorithms useful in the treatment of atrial fibrillation arrhythmia-Biventricular pacing in congestive heart failure-a boost toward finer living arrhythmia-Catheter ablation of atrial flutter and macroreentrant atrial tachycardia arrhythmia-Current clinical perspectives on implantable devices for atrial defibrillation arrhythmia-Implantable cardioverter defibrillator trials-what's new arrhythmia-Pacing for the prevention of atrial fibrillation arrhythmia-Permanent cardiac pacing to prevent vasovagal syncope arrhythmia-T wave alternans for ventricular arrhythmia risk stratification arrhythmia-underlying the long QT syndrome-Cellular mechanisms arrhythmia-underlying the long QT syndrome-Molecular mechanisms Arrhythmias-Autoantibodies-Emerging Upstream Targets of Arrhythmias and Sudden Death arrhythmias-Antiarrhythmic drugs in pregnancy arrhythmias-Antiarrhythmic drugs in pregnancy-1 arrhythmias-arrhythmias-Basic mechanisms of reentrant arrhythmias arrhythmias-Arrhythmogenic Right Ventricular Dysplasia arrhythmias-Arrhythmogenic Right Ventricular Dysplasia-1 arrhythmias-Atrial fibrillation-rate control versus maintenance of sinus rhythm arrhythmias-Atrial fibrillation-rate control versus maintenance of sinus rhythm-1 arrhythmias-Basic mechanisms of reentrant arrhythmias Arrhythmias-Current Status of the Implantable Cardioverter-Defibrillator arrhythmias-Function and structure of the mouse sinus node arrhythmias-Intravenous antiarrhythmic agents arrhythmias-Issues in the use of generic antiarrhythmic drugs arrhythmias-Management of implantable cardioverter defibrillator patients arrhythmias-Management of implantable cardioverter defibrillator patients-1 arrhythmias-management of surgical complications of pacemaker and implantable cardioverter-defibrillators-1 arrhythmias-ntravenous antiarrhythmic agents arrhythmia-Social and psychosocial influences on sudden cardiac death, ventricular arrhythmia Arrhythmias-Reperfusion Arrhythmias-New Insights into the Role of the Na+-Ca2+Exchanger arrhythmias-sues in the use of generic antiarrhythmic drugs-1 arrhythmias-The management of surgical complications of pacemaker and implantable cardioverter-defibrillators arrhythmias-Update on external cardioversion and defibrillation arrhythmias-Update on external cardioversion and defibrillation-1 arrhythmias-Use of implantable pacemakers and implantable defibrillators in hypertrophic cardiomyopathy arrhythmias-Use of implantable pacemakers and implantable defibrillators in hypertrophic cardiomyopathy-1 arrhythmias-Ventricular arrhythmias in the athlete arrhythmias-Ventricular arrhythmias in the athlete-1 Arrhythmic risk stratification of post–myocardial infarction patients Arrhythmic-Automated External Defibrillators-Technical Considerations and Clinical Promise Arrhythmic-Catheter ablation in the year 2000 Arrhythmic-Classification system of atrial fibrillation Arrhythmic-Clinical implication of antiembolic trials in atrial fibrillation Arrhythmic-Cost-effective strategies in the acute management of atrial fibrillation arrhythmic-Inherited Sodium Channelopathies_Novel Therapeutic and Proarrhythmic Arrhythmic-Inpatient versus outpatient antiarrhythmic drug initiation Arrhythmic-Long QT syndrome-Diagnosis and management Arrhythmic-New advances in class III antiarrhythmic drug therapy Arrhythmogenic Ionic Remodeling as-Coronary Heart Disease-Selective Estrogen Receptor Modulators and Coronary Heart Disease AS-A simple method to assess the oxidative susceptibility of low density lipoproteins as-Advances in Experimental Dyslipidemia and Atherosclerosis as-An unsolved mystery of promoter variation in CETP gene and atherosclerosis as-Analytical models of atherosclerosis AS-Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis as-Antibodies against oxidized LDL for non-invasive diagnosis of atherosclerotic vascular disease as-Antioxidants and atherosclerotic cardiovascular disease as-Atherosclerosis as an autoimmune disease-an update AS-Atherosclerotic renovascular disease-diagnosis and treatment as-Biomechanical-stress-induced Signaling and Gene Expression in the Development of Arteriosclerosis AS-Building a brain attack team to administer thrombolytic therapy for acute ischemic stroke AS-Carotid angioplasty and stenting-current status as-CD36-a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism as-CD40 Signaling and Plaque Instability as-CD40-CD40L Interactions in Atherosclerosis as-Characterization of atherosclerotic plaque by magnetic resonance imaging as-Chemokines-the link between inflammation, restenosis and atherosclerosis as-Chlamydia pneumonia (and other infective agents) in atherosclerosis and acute coronary syndromes as-Chlamydia pneumoniae and Atherosclerosis as-Class B Scavenger Receptors, Caveolae and Cholesterol Homeostasis as-Clinical Imaging of the High-Risk or Vulnerable Atherosclerotic Plaque as-Contribution of Adventitial Fibroblasts to Neointima Formation and Vascular Remodeling AS-C-Reactive protein, oxidative stress, homocysteine, and troponin and atherosclerosis as-Decorin Links Low-Density Lipoproteins (LDL) to Collagen; A Novel Mechanism for Retention of LDL in the Atherosclerotic Plaque AS-Design of the Intravenous Magnesium Efficacy in Acute Stroke (IMAGES) trial as-Domains of Apolipoprotein E Involved in the Binding to the Protein Core of Biglycan of the Vascular Extracellular Matrix as-Effect of menopause on plaque morphologic characteristics in coronary atherosclerosis AS-Emerging relations between infectious diseases and coronary artery disease and atherosclerosis as-Endogenous heparin activity deficiency-the `Missing Link' in atherogenesis as-Estrogen in the Prevention of Atherosclerosis as-Experimental atherosclerosis as-guidelines-Current guidelines for the management of unstable angina-a new diagnostic and management paradigm as-Guideline-The Lower the Better in Hypercholesterolemia Therapy-A Reliable Clinical Guideline as-Heat shock proteins and atherosclerosis as-Immune Mechanisms in Atherosclerosis as-Impact of Coronary Heart Disease on World Leaders as-Impaired Homocysteine Metabolism and Atherothrombotic Disease as-Influence of Caveolin, Cholesterol, and Lipoproteins on Nitric Oxide Synthase; Implications for Vascular Disease as-Ischemic heart disease-Adjunctive pharmacotherapy for coronary stenting as-Ischemic heart disease-Angiogenesis and the ischaemic heart as-Ischemic heart disease-Evolving concepts of vulnerable plaque and surgical and percutaneous methods of revascularization as-Ischemic heart disease-Haematocrit, viscosity, erythrocyte sedimentation rate-coronary heart disease as-Ischemic heart disease-Minimally invasive CABG as-Ischemic heart disease-Multivessel coronary artery disease-current revascularization strategies as-Ischemic heart disease-Patients, families and populations at high risk for coronary heart disease as-Ischemic heart disease-Role of cytokines in the pathogenesis of restenosis after percutaneous transluminal coronary angioplasty as-Ischemic heart disease-The 6-minute walk. A simple test with clinical application as-Ischemic heart disease-The thin-cap fibroatheroma-The major precursor lesion to acute coronary syndromes as-Ischemic heart disease-The use of mechanical devices as adjuncts to intracoronary stenting as-Ischemic heart disease-Transmyocardial laser revascularization as-Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 (LOX-1) in Atherogenesis as-Lipoprotein Modulation of Subendothelial Heparan Sulfate Proteoglycans (Perlecan) and Atherogenicity AS-Low-Density Lipoprotein Size, Pravastatin Treatment, and Coronary Events as-Lp A-I and Niacin-New Views of an Antiatherogenic Duo as-LRP-a multifunctional scavenger and signaling receptor as-Major risk factors and coronary heart disease as-Manipulating the vascular biology of coronary atherosclerosis in diabetes as-Methylenetetrahydrofolate reductase genotypes and predisposition to atherothrombotic disease as-MMP-8-a new target for atherosclerosis as-Multiple Mechanisms by Which Infection May Contribute to Atherosclerosis Development and Course as-Multivessel coronary artery disease-current revascularization strategies AS-New advances in the management of acute coronary syndromes-1. Matching treatment to risk as-New insights into atherosclerotic plaque rupture as-Oxidized LDL and HDL-antagonists in atherothrombosis as-p73 is a growth-regulated protein in vascular smooth muscle cells and is present at high levels in human atherosclerotic plaque as-Pathophysiological Events during Pregnancy Influence the Development of Atherosclerosis in Humans as-Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis as-Plaque cholesterol and calcium-the value of EBCT in the detection of coronary atherosclerosis AS-Platelet polymorphisms and ischemic heart disease-moving beyond traditional risk factors as-Platelets and the Injured Vessel Wall-Rolling into Action AS-Potential roles of the peroxisome proliferator-activated receptor g in macrophage biology and atherosclerosis as-PPAR and Atherosclerosis-Effects on Cell Growth and Movement as-Primary Prevention of Coronary Heart Disease as-Renal failure in atherosclerotic renovascular disease as-Role of apoA-II in lipid metabolism and atherosclerosis as-Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems as-scavenger receptor-CD36-a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation as-scavenger receptor-class A macrophage scavenger receptor (SR-A) multifunctional as-scavenger receptor-Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems as-Screening for subclinical deep-vein thrombosis as-Sialyltransferase activity of human plasma and aortic intima is enhanced in atherosclerosis as-Smooth muscle cells in coronary atherosclerotic plaques-phenotypic variation as-studies of the NAD(P)H oxidase in atherosclerosis as-The smooth muscle cell membrane during atherogenesis as-thyroid, blood flow and atheroma AS-Troponin measurements in ischemic heart disease as-Tumor Necrosis Factor Receptor and Ligand Superfamily Family Members TNFRSF14 and LIGHT-New Players in Human Atherogenesis as-Tumor Necrosis Factor Receptor Levels Are Associated With Carotid Atherosclerosis as-Tumor Necrosis Factor Receptor Superfamily 14 Is Involved in Atherogenesis by Inducing Proinflammatory Cytokines and Matrix Metalloproteinases AS-Rat aortic stenting as-scavenger receptor-LRP-a multifunctional scavenger and signaling receptor as-CD40-CD40L Interactions in Atherosclerosis as-MMP-8-a new target for atherosclerosis C cardiac heterogeneity cardiac heterogeneity-Assessing heterogeneous distribution of blood flow and metabolism in the heart cardiac heterogeneity-Correlation between heterogeneous myocardial flow and oxidative metabolism in normoxic and stunned myocardium cardiac heterogeneity-Doppler myocardial imaging. A new tool to assess regional inhomogeneity in cardiac function cardiac heterogeneity-Heterogeneity of metabolic parameters in the left ventricular myocardium and its relation to local blood flow cardiac heterogeneity-How heterogeneous is the cardiac autonomic innervation cardiac heterogeneity-Microheterogeneity of myocardial blood flow cardiac heterogeneity-Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart cardiac heterogeneity-Temporal fluctuations of myocardial high-energy phosphate metabolites with the cardiac cycle cardiac heterogeneity-The mechanical and metabolic basis of myocardial blood flow heterogeneity cardiac heterogeneity-Electrical heterogeneity within the ventricular wall cardiac heterogeneity-The heterogeneities of the heart Cardiomyopathy-New Concepts in Hypertrophic Cardiomyopathies Cardiomyocyte Hypertrophy-Apoptosis Signal-Regulating Kinase-Nuclear Factor-B-A Novel Signaling Pathway Regulates Cardiomyocyte Hypertrophy Cardiomyopathy and Sensorineural Hearing Loss-A Heritable Syndrome That Maps to 6q23–24 Cardiomyopathy and the Desmin Gene Cardiomyopathy Caused by a Novel-Tropomyosin Mutation (V95A) CARDIOMYOPATHY-The diagnosis of hypertrophic cardiomyopathy CARDIOMYOPATHY-The diagnosis of hypertrophic cardiomyopathy-1 CARDIOMYOPATHY-Activation of the Small GTP-binding Protein Ras in the Heart by Hypertrophic Agonists CARDIOMYOPATHY-Angiotensin II Type 2 Receptors and Cardiac Hypertrophy Cardiomyopathy-Athlete's Heart Electrocardiogram Mimicking Hypertrophic Cardiomyopathy CARDIOMYOPATHY-Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF-Metalloproteinase inhibitors as a new therapy cardiomyopathy-Cirrhotic cardiomyopathy-a pathophysiological review of circulatory dysfunction in liver disease Cardiomyopathy-Clinical Significance of Atrial Fibrillation in Hypertrophic Cardiomyopathy Cardiomyopathy-Contractile Dysfunction in Hypertrophic Cardiomyopathy_Elucidating Primary Defects of Mutant Contractile Proteins by gene transfer Cardiomyopathy-Current Status of Alcohol Septal Ablation for Patients with Hypertrophic Cardiomyopathy cardiomyopathy-Different expressivity of myosin light chain gene Ala57Gly mutation in hypertrophic cardiomyopathy cardiomyopathy-Dual Effects of Angiotensin II Type 2 Receptor on Cardiovascular Hypertrophy CARDIOMYOPATHY-Dual Effects of Angiotensin II Type 2 Receptor on Cardiovascular Hypertrophy-1 Cardiomyopathy-Dual-Chamber Pacing In Hypertrophic Cardiomyopathy Cardiomyopathy-Genetic Abnormalities Responsible For Dilated Cardiomyopathy Cardiomyopathy-Homozygous Mutation in Cardiac Troponin T-Implications for Hypertrophic Cardiomyopathy Cardiomyopathy-Human eHAND, but not dHAND, is Down-regulated in Cardiomyopathies CARDIOMYOPATHY-Inducible Activation of c-Myc in Adult Myocardium In Vivo Provokes Cardiac Myocyte Hypertrophy Cardiomyopathy-Insights into Pathogenesis and Treatment of Cytokines in Cardiomyopathy Cardiomyopathy-Metavinculin Mutations Alter Actin Interaction in Dilated Cardiomyopathy Cardiomyopathy-Molecular Genetics of Hypertrophic Cardiomyopathy cardiomyopathy-myosin light chain gene Ala57Gly mutation in familial hypertrophic cardiomyopathy Cardiomyopathy-Natural History of Hypertrophic Cardiomyopathy Cardiomyopathy-New Concepts in Hypertrophic Cardiomyopathies-2 Cardiomyopathy-Newly Created Splice Donor Site in Exon 25 of the MyBP-C Gene Is Responsible for Inherited Hypertrophic Cardiomyopathy Cardiomyopathy-Nitric Oxide and Viral Cardiomyopathy Cardiomyopathy-Prognostic implications of left ventricular hypertrophy cardiomyopathy-Prognostic implications of left ventricular hypertrophy-1 Cardiomyopathy-Role of Exercise Testing in the Evaluation of the Patient with Hypertrophic Cardiomyopathy cardiomyopathy-Sarcomere Protein Gene Mutations in Hypertrophic Cardiomyopathy CARDIOMYOPATHY-Shedding growth factors in cardiac hypertrophy Cardiomyopathy-Simvastatin Induces Regression of Cardiac Hypertrophy and Fibrosis and Improves Cardiac Function in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy Cardiomyopathy-SIV Cardiomyopathy in Non-Human Primates CARDIOMYOPATHY-Src and Multiple MAP Kinase Activation in Cardiac Hypertrophy CARDIOMYOPATHY-Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy Cardiomyopathy-Surgical Approaches to Dilated Cardiomyopathy cardiomyopathy-Targeted disruption of the gene for natriuretic peptide receptor-A worsens hypoxia-induced cardiac hypertrophy cardiomyopathy-The A-Type Lamins-Nuclear Structural Proteins as a Focus for Muscular Dystrophy and Cardiovascular Diseases cardiomyopathy-The emerging concept of mitochondrial cardiomyopathies cardiomyopathy-The failing heart cardiomyopathy-Viral myocarditis and dilated cardiomyopathy Cardiomyopathiy-New Concepts in Hypertrophic Cardiomyopathies Cardiovascular Biology Cardiovascular Biology and Medicine- Cardiovascular Biology and Medicine-Biochemical Assessment of Myocardial Fibrosis in Hypertensive Heart Disease Cardiovascular Biology and Medicine-Cardiomyocyte Apoptotic Cell Death in Arterial Hypertension Cardiovascular Biology and Medicine-Gene Therapy for Cardiovascular Disease-A Case for Cautious Optimism Cardiovascular Biology and Medicine-Genes Encoding Fibrinogen and Cardiovascular Risk Cardiovascular Biology and Medicine-Heart Failure-Interfering the Aldosterone-Cardiac Extracellular Matrix Relationship Cardiovascular Biology and Medicine-Heart Failure, Redox Alterations, and Endothelial Dysfunction Cardiovascular Biology and Medicine-Hyperhomocysteinemia in Liver Cirrhosis-Mechanisms and Role in Vascular and Hepatic Fibrosis Cardiovascular Biology and Medicine-Local Hemodynamic Changes in Hypertension-Insights for Therapeutic Preservation of Target Organs Cardiovascular Biology and Medicine-Molecular Basis of Salt Sensitivity in Human Hypertension Cardiovascular Biology and Medicine-Oxidative Stress in Arterial Hypertension-Role of NAD(P)H Oxidase Cardiovascular Biology and Medicine-Regeneration of the Myocardium Cardiovascular Biology and Medicine-Role of the Renin-Angiotensin System in Vascular Diseases Cardiovascular Biology and Medicine-Structural Adaptation of Vascular Networks cell-A Novel Role for STAT3 in Cardiac Remodeling cell-A Role for the Actin Cytoskeleton in the Initiation and Maintenance of Store-Mediated Calcium Entry in Human Platelets cell-Activation of the Small GTP-binding Protein Ras in the Heart by Hypertrophic Agonists cell-Adhesion receptors of vascular smooth muscle cells and their functions cell-Allocation and Early Differentiation of Cardiovascular Progenitors in the Mouse Embryo cell-Angiomotin Regulates Endothelial Cell Motility cell-Angiotensin II Induces Phenotype-Dependent Apoptosis in Vascular Smooth Muscle Cells cell-Apoptosis in the Heart-About Programmed Cell Death and Survival cell-Apoptosis of Smooth Muscle Cells Is Not Silent; Fas-FADD Initiates a Program of Inflammatory Gene Expression cell-Apoptosis of Smooth Muscle Cells Is Not Silent_Fas-FADD Initiates a Program of Inflammatory Gene Expression cell-Calcium Signal Transmission between Ryanodine Receptors and Mitochondria in Cardiac Muscle cell-Cardiac Myocyte Adenosine Receptors and Caveolae cell-Cardiac Na+-Ca2+ Exchange-Molecular and Pharmacological Aspects cell-cardioprotection-Modulation of sarcoplasmic reticulum function-A new strategy in cardioprotection cell-channe-an endothelial Ca2+ entry channel with dual mechanosensitivity cell-channel-Aquaporins-Phylogeny, Structure, and Physiology of Water Channels cell-channel-Ca2+-Activated Cl– Channels cell-channel-Cardiac channelopathies cell-channel-CFTR Chloride Channels-Binding Partners and Regulatory Networks cell-channel-Developmental Clustering of Ion Channels cell-channel-ERG Proteins and Functional Cardiac IKr Channels in Rat, Mouse, and Human Heart cell-channel-High-Throughput Screening Strategies for Cardiac Ion Channels cell-channel-Inherited Sodium Channelopathies; Novel Therapeutic and Proarrhythmic Molecular Mechanisms cell-channel-Ion Channels and Their Functional Role in Vascular Endothelium cell-channel-KCNQ potassium channels-physiology, pathophysiology, and pharmacology cell-channel-Molecular aspects of ATP-sensitive K+ channels in the cardiovascular system cell-channel-physiol-Extracellular Surface Charges in Voltage-Gated Ion Channels cell-channel-PI3King the L-Type Calcium Channel Activation Mechanism cell-channel-Postulated Role of Inter-domain Interaction within the Ryanodine Receptor in Ca2+ Channel Regulation cell-channel-Regulation of cardiac and smooth muscle Ca2+ channels (CaV1.2a,b) by protein kinases cell-channel-Regulation of the Cardiac Repolarizing HERG Potassium Channel by Protein Kinase A cell-Channels-High-Throughput Screening Strategies for Cardiac Ion Channels cell-channels-How Calcium Influx through Calcium Leak Channels Is Responsible for the Elevated Levels of Calcium-dependent Proteolysis in Dystrophic Myotubes cell-channel-Surface Expression of Kv1 Voltage-Gated K+ Channels Is Governed by a C-terminal Motif cell-chennal-Requirement of a Macromolecular Signaling Complex for Adrenergic Receptor Modulation of the KCNQ1-KCNE1 Potassium Channel cell-Current Perspective on the Role of Apoptosis in Atherothrombotic Disease cell-Cytochrome P450 2C is an EDHF Synthase in Coronary Arteries cell-Cytochrome P450 and Vascular Homeostasis cell-Decreased Expression of Insulin-like Growth Factor-1 and Apoptosis of Vascular Smooth Muscle Cells cell-Direct Vascular Effects of HMG-CoA Reductase Inhibitors cell-Distribution and role of Na+ase in endocardial endothelium cell-Endoglin-deficient Mice, a Unique Model to Study Hereditary Hemorrhagic Telangiectasia cell-Endoplasmic reticulum in the heart cell-Endothelial Cell Apoptosis-for Atherosclerosis cell-Endothelin-1 Synthesis and Receptor Expression in Human Coronary Artery Smooth Muscle Cells cell-Eph Receptors and Ephrin Ligands_Essential Mediators of Vascular Development cell-ErbB4 and Its Isoforms_Selective Regulation of Growth Factor cell-Exploring the Role of the-Adrenergic Receptor Kinase in Cardiac Disease Using Gene-Targeted Mice cell-Extracellular Matrix-Driven Matrix Metalloproteinase Production in Endothelial Cells Implications for Angiogenesis cell-Extracellular Matrix-Driven Matrix Metalloproteinase Production in Endothelial Cells; Implications for Angiogenesis cell-Functional Properties of Failing Human Ventricular Myocytes cell-Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart cell-Increased Rate of Apoptosis in Intimal Arterial Smooth Muscle Cells Through Endogenous Activation of TNF Receptors cell-Inhibition of Stress-Activated p38 Mitogen-Activated Protein Kinase Induces Low-Density Lipoprotein Receptor Expression cell-Integrating the VEGF Signals Leading to Actin-Based Motility in Vascular Endothelial Cells cell-Integrin and Growth Factor Receptor Crosstalk cell-Integrins and the Myocardium cell-Integrins in Vascular Development cell-Involvement of the cardiac ryanodine receptor-calcium release channel in catecholaminergic polymorphic ventricular tachycardia cell-Ligands for Peroxisome Proliferator-Activated Receptor Inhibit Monocyte CCR2 Expression Stimulated by Plasma Lipoproteins cell-Mitochondria and the heart cell-Mitochondria-Gateway for Cytoprotection cell-Mitochondrial coupling factor 6 as a potent endogenous vasoconstrictor cell-Mitochondrial Coupling Factor 6 Is Present on the Surface of Human Vascular Endothelial Cells cell-Molecular mechanisms of iNOS induction by IL-1 and IFN-in rat aortic smooth muscle cells cell-Myocardial Diseases cell-Peroxisome Proliferator–Activated Receptor-Ligands Inhibit Nuclear but Not Extracellular Signal-MAPK cell-Phospholipase A2 in Vascular Disease cell-Phospholipase C Isoforms, Cytoskeletal Organization, and Vascular Smooth Muscle Differentiation cell-PPAR agonists as direct modulators of the vessel wall in cardiovascular disease cell-PPAR Signaling in the Control of Cardiac Energy Metabolism cell-Regulation of MEF2 by p38 MAPK and Its Implication in Cardiomyocyte Biology cell-Regulation of the Cardiac Repolarizing HERG Potassium Channel by Protein Kinase A cell-Regulators of G-protein Signaling in Receptor Complexes cell-Salicylates and Vascular Smooth Muscle Cell Proliferation-Molecular Mechanisms for Cell Cycle Arrest cell-Salicylates and Vascular Smooth Muscle Cell Proliferation; Molecular Mechanisms for Cell Cycle Arrest cell-Sequence Determinants of Function and Evolution in Serine Proteases cell-Seven-transmembrane-spanning receptors and heart function cell-SH3 domains-complexity in moderation cell-Signaling of G12 Family of G Proteins Through a Tyrosine Kinase and a Ras-GAP cell-The Gas6-Axl System; A Novel Regulator of Vascular Cell Function cell-The Gas6-Axl System_A Novel Regulator of Vascular Cell Funct cell-Thrombin Stimulation of the Vascular Cell Adhesion Molecule-1 Promoter in Endothelial Cells Is Mediated by Tandem Nuclear Factor-B and GATA Motifs cell-Tissue Factor-dependent Factor VIIa Signaling cell-Upstream Stimulatory Factors Regulate Aortic Preferentially Expressed Gene-1 Expression in Vascular Smooth Muscle Cells cell-Vascular Smooth Muscle Growth-Autocrine Growth Mechanisms cell-Vascular endothelial cells express isoforms of protein kinase A inhibitor cell-Peroxisome Proliferator-activated Receptor g and Atherosclerosis channel-And then came the microelectrode channel-Voltage Sensing and Activation Gating of HCN Pacemaker Channels chennal-an endothelial Ca2+ entry channel with dual mechanosensitivity channel-Voltage Sensing and Activation Gating of HCN Pacemaker Channels Clinical Trials Clinical Trials in Cardiovascular Medicine Clinical trials- Clinical trials-Amiodarone-clinical trials Clinical trials-Clinical trials of coronary revascularization for chronic stable angina Clinical trials-Clinical trials of coronary revascularization Clinical trials-Clinical trials of revascularization therapy in diabetics clinical trials-Problems in dealing with missing data and informative censoring in clinical trials Clinical trials-Update on recent clinical trials in congestive heart failure C-reactive protein C-reactive protein after coronary stent implantation C-reactive protein and cardiac troponin for early risk stratification in patients with acute coronary syndromes C-reactive protein and dangerous liaisons C-reactive protein and primary prevention of ischemic heart disease C-Reactive Protein and secondary prevention of coronary events C-reactive protein-High sensitivity C-reactive protein for predicting cardiovascular disease-an inflammatory hypothesis C-reactive protein in healthy and in sick populations C-reactive protein, inflammation and atherosclerosis Intervention Cardiology current report-Intervention Cardiology-New Frontiers in Interventional Cardiology-Intravascular Radiation to Prevent Restenosis current report-Intervention Cardiology-Photodynamic therapy-shedding light on restenosis Current report-Interventional Cardiology-A Comparison of Tirofiban and Abciximab in Patients Undergoing Coronary Stent Implantation Current report-Interventional Cardiology-Acute and Chronic Pathophysiology of Transmyocardial Revascularization Current report-Interventional Cardiology-Advancing Antithrombin Therapy in Acute Myocardial Infarction Management-Low Molecular Weight Heparins Plus Fibrinolysis Current report-Interventional Cardiology-Alternative Approaches to Coronary Revascularization Current report-Interventional Cardiology-Angel Wings Das Devices for Atrial Septal Defect Closure Current report-Interventional Cardiology-Antiplatelet Therapy in AMI-Combining GP IIb-IIIa Inhibition with Reduced-dose Fibrinolytic Therapy Current report-Interventional Cardiology-Anti-restenosis Trials Current report-Interventional Cardiology-Aortoiliac Occlusive Disease-Surgical Versus Interventional Therapy Current report-Interventional Cardiology-Arteriogenesis-Angiogenesis within Unstable Atherosclerotic Plaque-Interactions with Extracellular Matrix Current report-Interventional Cardiology-Artificial Artercv Current report-Interventional Cardiology-Atheroablation Prior to Stents Current report-Interventional Cardiology-Basic Concepts of (Myocardial) Angiogenesis-Role of Vascular Endothelial Growth Factor and Angiopoietin Current report-Interventional Cardiology-Biodegradable Polymeric Stents Current report-Interventional Cardiology-Bivalirudin in Percutaneous Coronary Interventions and Acute Coronary Syndromes-New Concepts, New Directions Current report-Interventional Cardiology-Buttoned Device for Atrial Septal Defect Occlusion Current report-Interventional Cardiology-Buttoned Device Occlusion of Patent Ductus Arteriosus Current report-Interventional Cardiology-Bypass Without the Surgeon-The Coronary Veins as Arterial Conduits Current report-Interventional Cardiology-Cardiac Denervation and Cardiac Function Current report-Interventional Cardiology-Cardiac Magnetic Resonance Imaging for the Assessment of Myocardial Angiogenesis Current report-Interventional Cardiology-Carotid Artery Stent Placement Prior to Coronary Angioplasty or Coronary Bypass Graft Surgery Current report-Interventional Cardiology-Cellular cardiomyoplasty with autologous skeletal myoblasts for ischemic heart disease and heart failure Current report-Interventional Cardiology-Clopidogrel After Coronary Stenting Current report-Interventional Cardiology-Combination Enoxaparin and Abciximab During Percutaneous Coronary Intervention-A New Standard of Care current report-Interventional Cardiology-Combination of minimally invasive coronary PTCA treatment of double-vessel coronary disease Current report-Interventional Cardiology-Combined Local Angiogenesis and Surgical Revascularization for Coronary Artery Disease current report-Interventional Cardiology-Comparison of Tirofiban and Abciximab in Patients Undergoing Coronary Stent Implantation-Rationale, Design, and Results of the TARGET Trial Current report-Interventional Cardiology-Contrast Agents for Cardiac Angiography-Osmolality and Contrast Complications Current report-Interventional Cardiology-Coronary Artery Disease-Vascular Endothelial Growth Factor and Fibroblast Growth Factor current report-Interventional Cardiology-Coronary pressure and flow measurements in the cardiac catheterization laboratory current report-Interventional Cardiology-Coronary revascularization, when it needs to be done it needs to be done Current report-Interventional Cardiology-Coronary Ultrasound Thrombolysis-From Acute Myocardial Infarction to Saphenous Vein Grafts and Beyond Current report-Interventional Cardiology-Coronary Venous System-An Alternate Portal to the Myocardium for Diagnostic and Therapeutic Procedures in Invasive Cardiology Current report-Interventional Cardiology-Diabetes and Coronary Intervention-Special Considerations for Antithrombotic Therapy current report-Interventional Cardiology-Diabetes and Coronary Intervention-Special Considerations for Antithrombotic Therapy- Current report-Interventional Cardiology-Diagnosis of Renal Artery Stenosis-What is the Optimal Diagnostic Test current report-Interventional Cardiology-Distal Protection Devices During Percutaneous Saphenous Vein Graft Intervention-current report-Has a New Standard of Care Been Established Current report-Interventional Cardiology-Duct-Occlud for Occlusion of Patent Ductus Arteriosus Current report-Interventional Cardiology-Efficacy of Directional Atherectomy Prior to Stent Implantation Current report-Interventional Cardiology-Enhanced External Counterpulsation in Unrevascularizable Patients Current report-Interventional Cardiology-Eptifibatide in Percutaneous Coronary Intervention-The ESPRIT Trial Results Current report-Interventional Cardiology-Experience with ASDOS for Transcatheter Closure of Atrial Septal Defect and Patent Foramen Ovale Current report-Interventional Cardiology-'Facilitated' PCI for Acute MI-PCI with Lysis and Platelet Inhibition Current report-Interventional Cardiology-Femoropopliteal Occlusions-Experience with Peripheral Excimer Laser Angioplasty Current report-Interventional Cardiology-Fibroblast Growth Factors and Angiogenesis-Basic Considerations Current report-Interventional Cardiology-Fragmin and Other Low Molecular Weight Heparins in Coronary Intervention Current report-Interventional Cardiology-Gene Therapy for Coronary Restenosis-A Promising Strategy for the New Millennium Current report-Interventional Cardiology-Gene Transfer for Coronary Restenosis Current report-Interventional Cardiology-Gianturco Coil Occlusion of Patent Ductus Arteriosus current report-Interventional Cardiology-Guidelines on management (diagnosis and treatment) of syncope Current report-Interventional Cardiology-Helex Septal Occluder for Closure of Atrial Septal Defects Current report-Interventional Cardiology-Heparin-Coated Coronary Stents Current report-Interventional Cardiology-Historical Aspects of Transcatheter Closure of the Patent Ductus Arteriosus Current report-Interventional Cardiology-History of the Development of Atrial Septal Occlusion Devices Current report-Interventional Cardiology-Imaging Angiogenesis with Three-Dimensional Microscopic Computed Tomography Current report-Interventional Cardiology-Improving Endothelial Function with ACE Inhibitors-An Important Therapeutic Target After Coronary Interventions Current report-Interventional Cardiology-Infectious Agents, Antibiotics, and Coronary Artery Disease Current report-Interventional Cardiology-Infrapopliteal Endovascular Techniques-Indications, Techniques, and Results Current report-Interventional Cardiology-Integrilin, Intervention, and the Enhanced Suppression of the Platelet IIb-IIIa Receptor with Integrilin Therapy Trial Current report-Interventional Cardiology-Interventional Cardiology-Where Do We Stand Current report-Interventional Cardiology-Left Ventricular Mapping and Myocardial Revascularization Current report-Interventional Cardiology-Local Drug Delivery During Percutaneous Coronary Intervention Current report-Interventional Cardiology-Low Molecular Weight Heparin and Coronary Intervention Current report-Interventional Cardiology-Management of Acute Lower Extremity Ischemia-Treatment Strategies and Outcome Current report-Interventional Cardiology-Management of Atherosclerotic Renal Artery Stenosis-Interventional Versus Medical Therapy Current report-Interventional Cardiology-Mechanical Approaches for Myocardial Angiogenesis Current report-Interventional Cardiology-Mechanical Myocardial Injury and Angiogenesis-An Association with Therapeutic Potential for Advanced Ischemic Coronary Artery Disease Current report-Interventional Cardiology-Mechanisms of Efficacy-Safety Concerns and Early Results Current report-Interventional Cardiology-Monitoring of Platelet Function in the Setting of GPIIa-IIIb Inhibitor Therapy Current report-Interventional Cardiology-Moving Up the Coagulation Cascade-Potential Factor X Inhibition for Percutaneous Coronary Intervention Current report-Interventional Cardiology-New Approaches for Vascular Anastomoses Current report-Interventional Cardiology-New Developments in Therapeutic Ultrasound-Assisted Coronary Angioplasty Current report-Interventional Cardiology-New Thrombolytic Agents-Does Direct Angioplasty Still Have a Role Current report-Interventional Cardiology-Novel Aortic Reconstruction Strategies-Endovascular Aneurysm Repair Current report-Interventional Cardiology-Optimal Platelet Inhibition for PCI in ACS-Pretreatment, In-laboratory, Both or Neither Current report-Interventional Cardiology-Optimizing Coronary Interventions-Primary Stent Placement Whenever Possible Current report-Interventional Cardiology-Percutaneous Approach to Achieve Therapeutic Myocardial Angiogenesis Current report-Interventional Cardiology-Percutaneous Approach to Achieve Therapeutic Myocardial Angiogenesis-2 Current report-Interventional Cardiology-Percutaneous Myocardial Revascularization Current report-Interventional Cardiology-Potential of Cilostazol in Interventional Cardiology Current report-Interventional Cardiology-Radioactive Stents-A Dead End Current report-Interventional Cardiology-Radiocontrast Nephropathy Current report-Interventional Cardiology-Randomized Clinical Trials Current report-Interventional Cardiology-Rashkind and Clamshell Device Closure of Ventricular Septal Defect current report-Interventional Cardiology-Rashkind and Clamshell Device Closure of Ventricular Septal Defect- Current report-Interventional Cardiology-Recent Developments in Coated Stents Current report-Interventional Cardiology-Remodeling and Restenosis-Observations from Serial Intravascular Ultrasound Studies Current report-Interventional Cardiology-Renal Artery Stent Placement-Indications and Results Current report-Interventional Cardiology-Restenosis and Brachytherapy Current report-Interventional Cardiology-Restenosis and Hyperplasia-Animal Models Current report-Interventional Cardiology-Restenosis and Reocclusion after Recanalization of an Occluded Coronary Artery-Is There a Light at the End of This Tunnel current report-Interventional Cardiology-Restenosis and Reocclusion after Recanalization of an Occluded Coronary Artery-Is There a Light at the End of This Tunnel- Current report-Interventional Cardiology-Restenosis-Relationship with Thrombosis Current report-Interventional Cardiology-Review of Preclinical and Clinical Results with Vascular Endothelial Growth Factors for Therapeutic Angiogenesis Current report-Interventional Cardiology-Role of CardioSEAL and Starflex Devices in Atrial Defect Occlusion Current report-Interventional Cardiology-Rotational Coronary Atherectomy-Contemporary and Future Applications Current report-Interventional Cardiology-Sirolimus-coated Stent Prevents Neointimal Proliferation Current report-Interventional Cardiology-Subclavian and Innominate Revascularization-Surgical Therapy Versus Catheter-Based Intervention Current report-Interventional Cardiology-Summary and Comparison of Atrial Septal Defect Closure Devices Current report-Interventional Cardiology-Summary and Comparison of Patent Ductus Arteriosus Closure Devices Current report-Interventional Cardiology-Systematic Review of Hirudin in Acute Coronary Syndromes and Percutaneous Coronary Intervention Current report-Interventional Cardiology-The Role of the 'Sideris' Devices in the Occlusion of Ventricular Septal Defects current report-Interventional Cardiology-The Role of the 'Sideris' Devices in the Occlusion of Ventricular Septal Defects Current report-Interventional Cardiology-Therapeutic Angiogenesis Using Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor Using Various Delivery Strategies Current report-Interventional Cardiology-Therapeutic Angiogenesis Using Local Perivascular and Pericardial Delivery Current report-Interventional Cardiology-Training and Credentialing of Cardiologists in Peripheral Intervention Current report-Interventional Cardiology-Tranilast in the Therapy of Coronary Artery Disease Current report-Interventional Cardiology-Transcatheter Closure of Patent Ductus Arteriosus Using the Amplatzer Duct Occluder Current report-Interventional Cardiology-Transcatheter Closure of Secundum Atrial Septal Defects Using the Amplatzer Septal Occluder-Clinical Experience and Technical Considerations Current report-Interventional Cardiology-Transcatheter PDA Closure Using the Gianturco-Grifka Vascular Occlusion Device Current report-Interventional Cardiology-Treatment of Restenosis current report-Interventional Cardiology-Treatment of Restenosis Current report-Interventional Cardiology-Update on Abciximab Readministration During Percutaneous Coronary Interventions Current report-Interventional Cardiology-Update on Heparin Anticoagulation During Coronary Intervention Current report-Interventional Cardiology-Update on In-stent Restenosis current report-Interventional Cardiology-Update on In-stent Restenosis Current report-Interventional Cardiology-Update on Pharmacology for Restenosis Current report-Interventional Cardiology-Vertebral Insufficiency-When to Intervene and How current report-interventions Cardiology-PTCA in the treatment of double-vessel coronary disease current report-interventions Cardiology-stent-2001 transcatheter cardiovascular therapeutics current report-interventions Cardiology-stent-2001 transcatheter cardiovascular therapeutics-1 current report-interventions Cardiology-stent-2001 transcatheter cardiovascular therapeutics-2 current report-interventions Cardiology-stent-Acute coronary syndromes and acute myocardial infarction current report-interventions Cardiology-stent-Acute myocardial infarction current report-interventions Cardiology-stent-Cardiac surgery current report-interventions Cardiology-stent-Cardiovascular imaging current report-interventions Cardiology-stent-Carotid and peripheral vascular interventions current report-interventions Cardiology-stent-Congenital heart disease and vascular interventions current report-interventions Cardiology-stent-Coronary in-stent restenosis-predictors, treatment and prevention current report-interventions Cardiology-stent-Coronary interventions-clinical outcomes and non-stent current report-interventions Cardiology-stent-Coronary stent implantation-a panacea for the interventional cardiologist current report-interventions Cardiology-stent-Endovascular interventions current report-interventions Cardiology-stent-In-Stent restenosis and vascular brachytherapy current report-interventions Cardiology-stent-In-stent restenosis-experimental and clinical current report-interventions Cardiology-stent-Interventional pharmacology and acute ischemic syndromes current report-interventions Cardiology-stent-Interventional pharmacology current report-interventions Cardiology-stent-Multivessel and left main stenting current report-interventions Cardiology-stent-New stent designs current report-interventions Cardiology-stent-The radioactive stent-any chance of a resurrection current report-interventions Cardiology-stent-Vascular access and complications current report-interventions Cardiology-stent-Vascular acess and cmplications current report-interventions Cardiology-stent-Vascular brachytherapy current report-interventions Cardiology-Combination of invasive coronary bypass and PTCA in treatment of double-vessel coronary disease current report-interventions Cardiology-stent-Drug-Eluting stents Current report-Interventional Cardiology-Cilostazol for Prevention of Thrombosis and Restenosis After Intracoronary Stenting hypertension current report-hypertension-Angiotensin and Cytoskeletal Proteins-Role in Vascular Remodeling current report-hypertension-Cellular Phenotypes and the Genetics of Hypertension current report-hypertension-Endothelin Antagonists and Heart Failure current report-hypertension-Genetic Determinants of Vascular Reactivity current report-hypertension-Genetic Targeting of the Renin-Angiotensin System for Long-term Control of Hypertension current report-hypertension-Genetics of the Mineralocorticoid System in Primary Hypertension current report-hypertension-Microvascular Angiogenesis and the Renin-Angiotensin System current report-hypertension-Mild Physical Exercise May Activate the Adenosine-Dopamine System-A New Natriuretic Mechanism current report-hypertension-Nonhypertensive Cardiac Effects of a High Salt Diet current report-hypertension-Small Artery Remodeling in Hypertension current report-hypertension-Trial Report-Pathogenesis of Hypertension current report-hypertension-Trial Report-Vascular Mechanisms current report-hypertension-Vasopeptidase Inhibition-Effective Blood Pressure Control for Vascular Protection current report-Interventional Cardiology-Diabetes and Coronary Intervention-Special Considerations for Antithrombotic Therapy current report-Peroxisome Proliferator-activated Receptor and Atherosclerosis Current Reports-Hypertension Current Reports-Hypertension Current Reports-Hypertension-Adrenal and the Metabolic Syndrome Current Reports-Hypertension-Adrenomedullin in Hypertension Current Reports-Hypertension-Aldosterone and Vascular Damage Current Reports-Hypertension-Aldosterone-Related Genetic Effects in Hypertension Current Reports-Hypertension-Ambulatory Blood Pressure Monitoring Current Reports-Hypertension-Angiotensin Converting Enzyme Inhibitors-Are They Preferred First-line Therapy Current Reports-Hypertension-Angiotensin, Inflammation, Hypertension, and Cardiovascular Disease Current Reports-Hypertension-Angiotensin-converting Enzyme Inhibitors in Antihypertensive Therapy Current Reports-Hypertension-Antiatherogenic Effects of Antihypertensive Treatment-Trials Completed and Ongoing Current Reports-Hypertension-Antihypertensive Agents-Mechanisms of Drug Action Current Reports-Hypertension-Antihypertensive Agents-Mechanisms of Drug Actions Current Reports-Hypertension-Antihypertensive Agents-Patient Selection and Special Problems Current Reports-Hypertension-Antihypertensive Drug Therapy in the Third Millennium-Are There Benefits Beyond Blood Pressure Current Reports-Hypertension-Antihypertensive Drugs and Reversing of Endothelial Dysfunction in Hypertension Current Reports-Hypertension-Antihypertensive Therapy-Compliance, Quality of Life, and Pharmacoeconomics Current Reports-Hypertension-Antihypertensive Therapy in Pregnancy Current Reports-Hypertension-Antihypertensive Therapy-Patient Selection and Special Problems Current Reports-Hypertension-Antioxidants and Endothelial Dysfunction in Hyperlipidemia Current Reports-Hypertension-Are Sleep-related Breathing Disorders Important Contributing Factors to the Production of Essential Hypertension Current Reports-Hypertension-Atherosclerotic Renal Artery Stenosis-Surgery, Percutaneous Transluminal Angioplasty, or Medical Therapy Current Reports-Hypertension-Barriers to Hypertension Care and Control Current Reports-Hypertension-Calcium Channel Blocker Controversy in Patients with Diabetic Nephropathy-Is There an Issue Current Reports-Hypertension-Cardiovascular Risk and Hypertension Current Reports-Hypertension-Carotid Intima-media Thickness as a Measure of Vascular Target Organ Damage Current Reports-Hypertension-Central Nervous System Norepinephrine Metabolism in Hypertension Current Reports-Hypertension-Central Sympathoinhibitory Effects of Calcium Channel Blockers Current Reports-Hypertension-Cerebral White Matter Lesions in Essential Hypertension Current Reports-Hypertension-Circadian Rhythm of Blood Pressure in Renal Disease Current Reports-Hypertension-Context-dependent Genetic Effects in Hypertension Current Reports-Hypertension-Coronary Heart Disease Prevention As the Primary Goal in Contemporary Trials in the Treatment of Hypertension Current Reports-Hypertension-Cost per Millimeter of Mercury Lowering Is a Measure of Economic Value for Antihypertensive Agents Current Reports-Hypertension-Current Genetics of Essential Hypertension Current Reports-Hypertension-DASH Trials Implicate Dysfunction in Calcium Regulation in the Pathogenesis of Human Hypertension Current Reports-Hypertension-Diagnosis of High Blood Pressure in Children by Means of Ambulatory Blood Pressure Monitoring Current Reports-Hypertension-Diastolic Pressure, Systolic Pressure, or Pulse Pressure Current Reports-Hypertension-Do Most Antihypertensive Agents Have a Sympatholytic Action Current Reports-Hypertension-Doxazosin Arm of the ALLHAT Study Discontinued-How Equal Are Antihypertensive Drugs Current Reports-Hypertension-Effect of Antihypertensive Drugs on Vascular Compliance Current Reports-Hypertension-Effect of Hypertension on Viscoelasticity of Large Arteries in Humans Current Reports-Hypertension-Effects of Antihypertensive Therapy on Hypertensive Vascular Disease Current Reports-Hypertension-Effects of Blood Pressure and Glucose on Endothelial Function Current Reports-Hypertension-Endothelial Dysfunction and Atherosclerosis-Endothelin Receptor Antagonists as Novel Therapeutics Current Reports-Hypertension-Fat Cell Metabolism-Insulin, Fatty Acids, and Renin Current Reports-Hypertension-Free Radical Production and Angiotensin Current Reports-Hypertension-Future of Gene Therapy for Stroke Current Reports-Hypertension-Gene Therapy at the Clinical Horizon Current Reports-Hypertension-Gene Therapy of Hypertensive Vascular Injury Current Reports-Hypertension-Genetic Contributions to Left Ventricular Hypertrophy Current Reports-Hypertension-Genetic Rat Models of Hypertension-Relationship to Human Hypertension Current Reports-Hypertension-Heredity and the Autonomic Nervous System in Human Hypertension Current Reports-Hypertension-How Aggressively Should Blood Pressure Be Treated in Renal Transplant Recipients Current Reports-Hypertension-How Long Should Telomeres Be Current Reports-Hypertension-Hypertension and Current Issues in Compliance and Patient Outcomes Current Reports-Hypertension-Hypertension and Ischemic Nephropathy Current Reports-Hypertension-Hypertension and Metabolic Disarray-Diabetes Mellitus, Insulin Resistance and Obesity Current Reports-Hypertension-Hypertension and Single Nucleotide Polymorphisms Current Reports-Hypertension-Hypertension and the Heart Current Reports-Hypertension-Hypertension in Patients Presenting with Stroke Current Reports-Hypertension-Hypertension in the HIV-Infected Patient Current Reports-Hypertension-Hypertension-induced Organ Damage in African Americans-Transforming Growth Factor-b1 Excess as a Mechanism for Increased Prevalence Current Reports-Hypertension-Hypertension-Kidney, Sodium, and the Renin-Angiotensin System Current Reports-Hypertension-Hyperuricemia and Renal Function Current Reports-Hypertension-Importance of Various Methods of Blood Pressure Measurement in Clinical Trials Current Reports-Hypertension-Improvement of Endothelial Dysfunction as a Surrogate Endpoint in the Treatment of Hypertension Current Reports-Hypertension-Individualized Versus Indiscriminate Therapy for Hypertension Current Reports-Hypertension-Influence of National Guidelines on Antihypertensive Prescribing Patterns Current Reports-Hypertension-Insulin and the Vasculature Current Reports-Hypertension-Interaction Between Leptin and Sympathetic Nervous System in Hypertension Current Reports-Hypertension-Is There a Preferred Antihypertensive Therapy for Isolated Systolic Hypertension and Reduced Arterial Compliance Current Reports-Hypertension-Knockout of Renin-Angiotensin System Genes-Effects on Vascular Development Current Reports-Hypertension-Lessons Learned from Prematurely Terminated Clinical Trials Current Reports-Hypertension-Management of Postural Hypotension Current Reports-Hypertension-Mechanism of Differential Effects of Antihypertensive Agents on Serum Lipids Current Reports-Hypertension-Mental Stress As a Causal Factor in the Development of Hypertension and Cardiovascular Disease Current Reports-Hypertension-Metabolic Syndrome and Related Cardiovascular Risk Current Reports-Hypertension-Methods and Applications of Quality-of-Life Measurement During Antihypertensive Therapy Current Reports-Hypertension-Mouse Models of Blood Pressure Regulation and Hypertension Current Reports-Hypertension-Need to Lower Systolic Blood Pressure Current Reports-Hypertension-New Developments in Mechanisms of Obesity-induced Hypertension-Role of Adipose Tissue Current Reports-Hypertension-New Trends in the Treatment of Orthostatic Hypotension Current Reports-Hypertension-Nighttime Blood Pressure in Elderly Hypertensive Patients Current Reports-Hypertension-Nonesterified Fatty Acids in Blood Pressure Control and Cardiovascular Complications Current Reports-Hypertension-Observational Studies of Antihypertensive Medication Use and Compliance-Is Drug Choice a Factor in Treatment Adherence Current Reports-Hypertension-Optimal Antihypertensive Therapy for Prevention and Treatment of Left Ventricular Hypertrophy Current Reports-Hypertension-Optimal Strategies for Preventing Progression of Renal Disease-Should Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Be Used Together Current Reports-Hypertension-Oxidative Stress and Vascular Damage in Hypertension Current Reports-Hypertension-Pathogenesis of Hypertension-Genetic and Environmental Factors Current Reports-Hypertension-Pathophysiology of Obesity Hypertension Current Reports-Hypertension-Prehypertension-A Possible Target for Antihypertensive Medication Current Reports-Hypertension-Preventing Renal Disease Progression-Is It the Drug or the Blood Pressure Reduction, or Both Current Reports-Hypertension-Primary Aldosteronism-Rare Bird or Common Cause of Secondary Hypertension Current Reports-Hypertension-Problems in the Control of Systolic Blood Pressure Current Reports-Hypertension-Promise of Selective Aldosterone Receptor Antagonists for the Treatment of Hypertension and Congestive Heart Failure Current Reports-Hypertension-Prospective Trials of Angiotensin Receptor Blockers-Beyond Blood Pressure Control Current Reports-Hypertension-Prospectively Designed Overviews of Recent Trials Comparing Antihypertensive Regimens Based on Different Drug Classes Current Reports-Hypertension-Protection from Vascular Risk in Diabetic Hypertension Current Reports-Hypertension-Psychologic Factors as Precursors to Hypertension Current Reports-Hypertension-Racial Differences and the Genetics of Hypertension Current Reports-Hypertension-Recent Advances in the Management of Hypertension in the Elderly Current Reports-Hypertension-Recent Clinical Trial Highlights in Hypertension Current Reports-Hypertension-Recommendations for First-Line Antihypertensive Drugs and Combination Therapies Current Reports-Hypertension-Regulation of Sodium-Potassium ATPase Activity-Impact on Salt Balance and Vascular Contractility Current Reports-Hypertension-Renal Dopamine and Sodium Homeostasis Current Reports-Hypertension-Resistant Hypertension and the Birmingham Hypertension Square Current Reports-Hypertension-Review of Recent Framingham Study Hypertension Research Current Reports-Hypertension-RhoA-Rho-kinase, Vascular Changes, and Hypertension Current Reports-Hypertension-Role of Adhesion Molecules in Vascular Regulation and Damage Current Reports-Hypertension-Role of b2-Adrenergic Receptor Variation in Human Hypertension Current Reports-Hypertension-Role of the Nervous System in Hypertension Current Reports-Hypertension-Role of the Sympathetic Nervous System in Human Renovascular Hypertension Current Reports-Hypertension-Salt and Blood Pressure-What's New Current Reports-Hypertension-Secondary Hypertension-Adrenal and Nervous System Mechanisms Current Reports-Hypertension-Selecting the Right Drug for Initial Antihypertensive Therapy Current Reports-Hypertension-Sex-related Differences in the Insulin Resistance Syndrome Current Reports-Hypertension-Sodium Sensitivity, Not Level of Salt Intake, Predicts Salt Effects Current Reports-Hypertension-Special Situations in the Management of Hypertension Current Reports-Hypertension-Spironolactone in Congestive Heart Failure Current Reports-Hypertension-Statins and Blood Pressure Regulation Current Reports-Hypertension-Strategy for Uncovering Complex Determinants of Hypertension Using Animal Models Current Reports-Hypertension-Studies Examining Risk Reduction in Subjects with Multiple Metabolic and Cardiovascular Risk Factors Current Reports-Hypertension-Syndrome X Following Renal Transplantation Current Reports-Hypertension-Telomeres-The Time Factor in Essential Hypertension Current Reports-Hypertension-The Benefit of Treating Isolated Systolic Hypertension Current Reports-Hypertension-Therapeutic Potential of Endothelin Receptor Antagonists in Cardiovascular Disease Current Reports-Hypertension-Therapeutic Trials Comparing Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Current Reports-Hypertension-Transgenic and Knockout Mice to Study the Renin-angiotensin System and Other Interacting Vasoactive Pathways Current Reports-Hypertension-Treatment of Hypertension in Diabetes Mellitus Current Reports-Hypertension-Treatment of Hypertension in the Hemodialysis Patient-Beneficial or Not Current Reports-Hypertension-Update-Role of the Angiotensin Type-2 (AT2) Receptor in Blood Pressure Regulation Current Reports-Hypertension-Use of Designer Rats in the Genetic Dissection of Hypertension Current Reports-Hypertension-Use of Gene Markers to Guide Antihypertensive Therapy Current Reports-Hypertension-Use of Single Nucleotide Polymorphisms for Gene Discovery in Hypertension Current Reports-Hypertension-Vascular mechanisms Current Reports-Hypertension-Vasopeptidase Inhibition-A New Direction in Cardiovascular Treatment Current Reports-Hypertension-What Can Knockout Mice Contribute to an Understanding of Hypertension Current Reports-Hypertension-What Is the Optimal Strategy to Intensify Blood Pressure Control and Prevent Progression of Renal Failure Current Reports-Hypertension-Xenobiotics, Dietary Interventions, and Genetically Mediated Therapies atherosclerosis Current Reports-Role of Central Mineralocorticoid Receptors in Cardiovascular Disease Current Reports-Serum Uric Acid As a Cardiovascular Risk Factor for Heart Disease Current Reports-Advances In Device Lead Extraction Current Reports-Alcohol and Cardiovascular Disease Current Reports-An Evidence-based Approach to Diagnosing Renovascular Hypertension Current Reports-Analysis of Dual-Chamber Pacing as a Treatment for Refractory Limiting Symptoms in Patients with Obstructive Hypertrophic Cardiomyopathy Current Reports-Angiotensin-converting Enzyme Inhibitor and Aspirin Interaction in Congestive Heart Failure-Fear or Reality Current Reports-Antiatherogenic Components of Olive Oil Current Reports-Antibiotic Therapy for Treatment of Chlamydia to Prevent Coronary Heart Disease Events Current Reports-Anticoagulant Therapy in Special Circumstances Current Reports-Anticoagulation and Heart Failure Current Reports-Anticoagulation for Acute Coronary Syndromes and Percutaneous Coronary Intervention in Patients with Heparin-induced Thrombocytopenia Current Reports-Antioxidants and Vitamins to Reduce Cardiovascular Disease Current Reports-Antiphospholipid Syndrome, Antiphospholipid Antibodies, and Atherosclerosis Current Reports-Antithrombotic Therapy for Prosthetic Valves-Routine Treatment and Special Considerations Current Reports-Antithrombotic Therapy for Valve Disease-Native and Prosthetic Valves Current Reports-Antithrombotic Therapy in Cardiac Stent Patients Current Reports-Antithrombotic Therapy in Chronic Heart Disease Current Reports-Antithrombotic Therapy in the Cardiac Catheterization Laboratory-Focus on Antiplatelet Agents Current Reports-Antithrombotics and Acute Coronary Syndromes Current Reports-Antithrombotics in the Management of Patients with Acute Coronary Current Reports-Are All b-Blockers the Same for Chronic Heart Failure Current Reports-Are Drugs and Catheter Ablation Effective for Treating Ventricular Arrhythmias Current Reports-Are Implantable Cardioverter-Defibrillators Cost-Effective Current Reports-Are Statins Anti-Inflammatory-Inflammation C-Reactive Protein Current Reports-Assessment and Management of Lipid Abnormalities Current Reports-Assessment of Management of Lipid Abnormalities Current Reports-Asymptomatic Left Ventricular Dysfunction in the Community Current Reports-Athletes Heart and Hypertrophic Cardiomyopathy Current Reports-Benefits of Niacin in Atherosclerosis Current Reports-Beta-Blockers and Spironolactone in Heart Failure Current Reports-Beta-Carotene, Vitamin C, and Vitamin E and Cardiovascular Diseases Current Reports-Beyond Cholesterol Lowering-Deciphering the Benefits of Dietary Intervention on Cardiovascular Diseases Current Reports-Biologic Alternatives to Stents and Grafts Current Reports-Bivalirudin for Percutaneous Coronary Intervention and in Acute Coronary Syndromes Current Reports-Cardiac Markers in the Diagnosis of Acute Coronary Syndromes Current Reports-Cardiomyopathy and Embolization-Risks and Benefits of Anticoagulation in Sinus Rhythm Current Reports-Catheter Ablation of Ventricular Tachycardia Related to Coronary Artery Disease-The Role of Noncontact Mapping Current Reports-Chlamydia Pneumoniae and Atherosclerosis Current Reports-Clinical and Interventional Electrophysiology Current Reports-Clinical Characteristics and Catheter Ablation of Left Ventricular Outflow Tract Tachycardia Current Reports-Clinical Implications of Elevated Lipoprotein(a) Current Reports-Clinical Trial Evidence for the Cardioprotective Effects of Omega-3 Fatty Acids Current Reports-Clinical Trials in Gene Therapy Current Reports-Closed Chest Totally Endoscopic Coronary Artery Bypass Surgery-Fantasy or Reality Current Reports-Colchicine Treatment for Recurrent Pericarditis Current Reports-Combination Lipid-Altering Therapy-An Emerging Treatment Paradigm for the 21st Century Current Reports-Complex Connection Between CD36 and Atherosclerosis, Lipid Metabolism, and Insulin Resistance Syndromes Current Reports-Complications of Oral Antiplatelet Medications Current Reports-Congenital Heart Disease-Current Indications for Antithrombotic Therapy in Pediatric Patients Current Reports-Congenital Heart Disease Current Reports-Constraint-Induced Movement Therapy to Enhance Recovery after Stroke Current Reports-Controversies about Tissue Plasminogen Activator-Extending the Window of Therapy Current Reports-Coronary Anastomotic Devices-Theory and Patented Ideas on Micromechanical Fastening Current Reports-Coronary Heart Disease-Clinical Trials Review Current Reports-Current Issues of Gene Therapy for Cardiovascular Disorders and Antithrombotic Therapy in Chronic Heart Disease Current Reports-Current Management of Patients with Pulmonary Hypertension and Right Ventricular Insufficiency Current Reports-Current Reports-Current Reports-Atherogenesis and the Arginine Hypothesis Current Reports-Current Reports-Plaque Angiogenesis and Atherosclerosis Current Reports-Current Reports-Primary Prevention of Heart Disease in Women Current Reports-Current Reports-The Need for Medicine-Based Evidence As Well as Evidence-Based Medicine Current Reports-Deactivation of the Sympathetic Nervous System in Patients with Chronic Congestive Heart Failure Current Reports-Deep Venous Thrombosis Prophylaxis in Patients with Heart Disease Current Reports-Diabetes and Cardiovascular Disease Current Reports-Diabetes-Statins, Fibrates, or Both- Current Reports-Diagnosis and Treatment of Hyperhomocysteinemia Current Reports-Diastolic Function in Hypertension Current Reports-Diastolic Heart Failure in the Community Current Reports-Diet and Coronary Heart Disease-Clinical Trials Current Reports-Diet and Pharmacologic Therapy of Obesity to Modify Atherosclerosis Current Reports-Dietary Fiber Prevents Carbohydrate-induced Hypertriglyceridemia Current Reports-Differences in Outcome Between Percutaneous Coronary Intervention and Coronary Bypass Grafting Current Reports-Differentiation in the Angiotensin II Receptor 1 Blocker Class on Autonomic Function Current Reports-Dilated Cardiomyopathy Current Reports-Effects of Fish Oils and Fish on Cardiovascular Disease Current Reports-Effects of Neurohormonal Antagonism on Pathologic Left Ventricular Remodeling in Heart Failure Current Reports-Electron Beam Tomography As an Endpoint for Clinical Trials of Antiatherosclerotic Therapy Current Reports-Emerging Indications for Permanent Pacing Current Reports-Endothelial Function As a Therapeutic Target in Coronary Artery Disease Current Reports-Epidemiology and Pathophysiology of Heart Failure Current Reports-Epidemiology and Pathophysiology of Heart Failure-1 Current Reports-Evolving Technology for Coronary and Valvular Surgery Current Reports-Failing Energetics in Failing Hearts Current Reports-Functional Foods and Cardiovascular Disease Current Reports-Gene-Diet Interaction and Plasma Lipid Response to Dietary Intervention Current Reports-Genes and Environment in Type 2 Diabetes and Atherosclerosis in Aboriginal Canadians Current Reports-Genetic Counseling for Congenital Heart Disease-New Approaches for a New Decade Current Reports-Genetics of Atherosclerosis-The Search for Genes Acting At the Level of the Vessel Wall Current Reports-Genetics of Venous and Arterial Thromboembolism Current Reports-Genomics and the Pathophysiology of Heart Failure Current Reports-Global Risk Assessment for Lipid Therapy to Prevent Coronary Heart Disease Current Reports-Good Smooth Muscle Cells in Atherosclerosis Current Reports-Guidelines for the Acute Coronary Syndromes Current Reports-Heart Failure in Blacks-Etiologic and Epidemiologic Differences Current Reports-Herbs and Atherosclerosis Current Reports-High-density Lipoprotein Metabolism-Molecular Targets for New Therapies for Atherosclerosis Current Reports-Hormone Replacement Therapy and Cardiovascular Risk Current Reports-Hormone Replacement Therapy for Prevention of Coronary Heart Disease-Current Evidence Current Reports-Hormone Replacement Therapy in the Prevention and Treatment of Atherosclerosis Current Reports-Hyperglycemia and Cardiovascular Disease Current Reports-Hypertrophic Cardiomyopathy Current Reports-Imaging Techniques to Predict Cardiovascular Risk Current Reports-Implantable Dual-Chamber Cardioverter-Defibrillator-Pacemaker Current Reports-Implications of Recent Heart Failure Trials for Patients with Hypertension Current Reports-Implications of the Atorvastatin Versus Revascularization Treatment (AVERT) Study for the Clinician Current Reports-Insulin Resistance in Human Partial Lipodystrophy Current Reports-Is There a Role for Calcium Channel Blockers in Congestive Heart Failure Current Reports-Ischemic Heart Disease Current Reports-Issues and Challenges with Antithrombotic Therapy in Diabetic Patients with Acute Coronary Syndromes Current Reports-Leadership in Academic Medicine-A Personal Perspective Current Reports-Levosimendan-A Promising Agent for the Treatment of Hospitalized Patients with Decompensated Heart Failure Current Reports-Low Molecular Weight Heparins and Coronary Artery Disease Current Reports-Low-Density Lipoprotein Apheresis in the Treatment of Atherosclerosis and Other Potential Uses Current Reports-Low-level Inotropic Stimulation with Type III Phosphodiesterase Inhibitors in Patients with Advanced Symptomatic Chronic Heart Failure Receiving b-blocking Agents Current Reports-Low-Molecular Weight Heparins in Coronary Artery Disease Current Reports-Management of Atrial Flutter Current Reports-Management of Heart Failure Current Reports-Management of Ventricular Arrhythmias in Adults with Congenital Heart Disease Current Reports-Management of Ventricular Arrhythmias Current Reports-Management of Ventricular Tachycardia in Patients with Clinically Normal Hearts Current Reports-Measurement of Cholesterol in Plasma and Other Body Fluids Current Reports-Medical Treatment of Hypertrophic Cardiomyopathy Current Reports-Methods of Minimizing Inappropriate Implantable Cardioverter-Defibrillator Shocks Current Reports-Minimal Access Aortic Root, Valve, and Complex Ascending Aortic Surgery Current Reports-Minimal Access Reoperative Mitral and Aortic Valve Surgery Current Reports-Mitral Ring Annuloplasty-An Incomplete Correction of Functional Mitral Regurgitation Associated with Left Ventricular Remodeling Current Reports-Myocardial Matrix and the Development and Progression of Ventricular Remodeling Current Reports-Natriuretic Peptides in the Pathophysiology of Congestive Heart Failure Current Reports-New Concepts in Fibrinolysis and Angiogenesis Current Reports-New Concepts in Vascular Nitric Oxide Signaling Current Reports-New Developments in Atherosclerosis Imaging-Electron Beam Tomography Current Reports-New Developments in the Detection of Vulnerable Plaque Current Reports-New Developments in the Prevention of Atherosclerosis in Patients with Low High-density Lipoprotein Cholesterol Current Reports-New Statins and New Doses of Older Statins Current Reports-Novel Inhibitors of Factor X for Use in Cardiovascular Diseases Current Reports-Novel Neurohumoral Factors in Congestive Heart Failure-Adrenomedullin Current Reports-Nutritional Interventions in Cardiovascular Disease-New Challenges and Opportunities Current Reports-Optimal Dietary Strategy to Manage Risk Associated with Various Dyslipidemias Current Reports-Oral Glycoprotein IIb-IIIa Antagonists in Coronary Artery Disease Current Reports-Oral Platelet Glycoprotein IIb-IIIa Inhibition Current Reports-Oxidative Stress in Congestive Heart Failure Current Reports-Pacemakers and Defibrillators for Congestive Heart Failure Current Reports-Pathophysiologic Mechanisms in Pericardial Disease Current Reports-Pathophysiology and Treatment of The Dyslipidemia of Insulin Resistance Current Reports-Pathophysiology of Atherosclerosis-Development, Regression, Restenosis Current Reports-Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction Current Reports-Percutaneous Coronary Intervention Versus Medical Therapy for Coronary Heart Disease Current Reports-Percutaneous Transluminal Septal Myocardial Ablation Current Reports-Peroxisome Proliferator-activated Receptors in Vascular Biology and Atherosclerosis-Emerging Insights for Evolving Paradigms Current Reports-Perspectives on Cardiac Allograft Vasculopathy Current Reports-Platelet Activation in Acute Myocardial Infarction and the Rationale for Combination Therapy Current Reports-Platelet Glycoprotein IIb-IIIa Inhibitors for Acute Coronary Syndromes-Initiate Treatment Early or Wait for the Catheterization Laboratory Current Reports-Platelet Glycoprotein Receptor Site Blockade in Coronary Artery Disease Current Reports-Platelet-Endothelial Interactions in Atherosclerosis Current Reports-Post-Stroke Depression-An Update Current Reports-Post-Stroke Epilepsy Current Reports-potential of the Angiotensin II Receptor 1 Blocker Eprosartan in the Management of Patients with Hypertension or Heart Failure Current Reports-Potential Use of Ca Scanning to Determine the Need for and Intensity of Lipid-lowering Therapy in Asymptomatic Adults Current Reports-Power of Food to Improve Multiple Cardiovascular Risk Factors Current Reports-Prevention of Restenosis with Intravascular beta-Radiotherapy Current Reports-Prevention of Ventricular Arrhythmias in the Congenital Long QT Syndrome Current Reports-Prevenzione Trial on Fish Oil and Vitamin E Supplementation in Myocardial Infarction Survivors Current Reports-Primary Prevention of Coronary Heart Disease Current Reports-Prophylactic Defibrillator Implantation in Patients with Coronary Artery Disease Current Reports-Radiofrequency Catheter Ablation of Atrial Fibrillation Initiated by Spontaneous Ectopic Beats Current Reports-Rational Use of Inotropic Therapy in Heart Failure Current Reports-Recent Developments in Microvascular Angina Current Reports-Recent Role of Imaging in the Diagnosis of Pericardial Disease Current Reports-Regulation of Cell Migration in Atherosclerosis Current Reports-Renin Angiotensin System As a Risk Factor for Coronary Artery Disease Current Reports-Results of the Assessment of Treatment with Lisinopril and Survival Trial Current Reports-Role of Angiotensin-converting Enzyme Inhibitors in the Treatment of Hypertension Current Reports-Role of Chemokines in Atherosclerosis Current Reports-Role of C-Reactive Protein in Cardiovascular Disease Risk Current Reports-Role of Diet in the Prevention and Treatment of Hypertension Current Reports-Role of Endothelin Receptor Antagonists in the Treatment of Chronic Heart Failure Current Reports-Role of Fibric Acids in Atherosclerosis Current Reports-Role of Lipoprotein(a) in the Pathogenesis of Atherosclerotic Cardiovascular Disease and Its Utility as Predictor of Coronary Heart Disease Events Current Reports-Role of Lipoprotein[a] in Atherosclerosis Current Reports-Role of Nitrogen Oxides on Eicosanoid Production During Atherosclerosis-Understanding the Controversies Current Reports-Role of Pharmacologic Treatment to Prevent Sudden Death in the Implantable Cardioverter Defibrillator Era Current Reports-Selective or Nonselective b-Adrenergic Blockade in Patients with Congestive Heart Failure Current Reports-Serum Uric Acid Is Not an Independent Risk Factor for Coronary Heart Disease Current Reports-Should Patients with Asymptomatic Wolff-Parkinson-White Pattern Undergo a Catheter Ablation Current Reports-Soy Proteins and Cardiovascular Disease Current Reports-Statin Therapy and Prevention of Stroke Current Reports-Statin Trials in Progress-Unanswered Questions Current Reports-Statins in Children-What Do We Know and What Do We Need to Do Current Reports-Statins, Hormones, and Women-Benefits and Drawbacks for Atherosclerosis and Osteoporosis Current Reports-Strategies for Catheter Ablation of Scar-related Ventricular Tachycardia Current Reports-Stress Echocardiography in the Diagnosis of Coronary Artery Disease Current Reports-Stroke and Cognition Current Reports-Stroke Prevention in Atrial Fibrillation Current Reports-Surgical Alternatives to Transplantation and Assist Devices in the Treatment of Heart Failure Current Reports-Sympathetic Overactivity in Hypertension-A Risk Factor for Cardiovascular Disease Current Reports-Systolic Hypertension and Cardiovascular Risk Reduction-A Clinical Review Current Reports-Targeting Triglycerides as Prognostic Indicators and Determining Lowest Values for Patient Benefit Current Reports-The Definitions of Acute Coronary Syndrome, Myocardial Infarction, and Unstable Angina Current Reports-The Risk of Congestive Heart Failure-Sobering Lessons from the Framingham Heart Study Current Reports-The Role of Fibric Acid Derivatives in the Secondary Prevention of Coronary Heart Disease Current Reports-The Role of Tumor Necrosis Factor Alpha in the Pathophysiology of Congestive Heart Failure Current Reports-Therapeutic Angiogenesis-Theoretic Problems Using Vascular Endothelial Growth Factor Current Reports-Therapeutic Implications of Escape from Angiotensin-Converting Enzyme Inhibition in Patients with Chronic Heart Failure Current Reports-Therapeutic Modulation of Cellular Cholesterol Efflux Current Reports-Therapeutic Options in Patients with Reduced Ejection Fraction and Nonsustained Ventricular Tachycardia Current Reports-To Define Is Divine Current Reports-Translating Heart Failure Guidelines into Clinical Practice-Clinical Science and the Art of Medicine Current Reports-Treating Ambulatory Ischemia in Coronary Disease by Manipulating the Cell Biology of Atherosclerosis Current Reports-Treatment of Coexisting Diabetes and Hypertension Current Reports-Treatment of Dyslipidemia in Pre-and Postmenopausal Women With and Without Known Atherosclerotic Cardiovascular Disease Current Reports-Treatment Strategies for Microvascular Dysfunction Following Acute Myocardial Infarction Current Reports-Trial Report-Plant Phytoestrogens Reduce the Risk of Coronary Heart Disease Current Reports-Trial Report-Some Implications from the Hypertension Optimal Treatment Study for Recent Recommendations Concerning Guidelines for the Treatment of Hypertension Current Reports-Triglyceride, Small, Dense Low-density Lipoprotein, and the Atherogenic Lipoprotein Phenotype Current Reports-Use of Statins in Acute Coronary Syndromes-The Mechanisms Behind the Outcomes Current Reports-Utility of Intracardiac Echocardiography in Interventional Electrophysiology Current Reports-Vectors for Gene Therapy of Cardiovascular Disease Current Reports-velopment and Assessment of Antiatherosclerotic Therapies Beyond Low-density Lipoprotein Cholesterol and Blood Pressure Current Reports-Ventricular Arrhythmias, Sudden Death, and Prevention in Patients with Hypertrophic Cardiomyopathy Current Reports-Ventricular Tachycardia Catheter Ablation in Arrhythmogenic Right Ventricular Dysplasia-A 16-year Experience Current Reports-Ventricular Unloading and Myocyte Recovery-Insight Gained into the Pathophysiology of Congestive Heart Failure Current Reports-Weighing the Evidence for Infection as a Risk Factor for Coronary Heart Disease Current Reports-What Has Intravascular Ultrasound Taught Us About Plaque Biology Current Reports-What Niche Will Newer Class III Antiarrhythmic Drugs Occupy Current Reports-Will the Real Heart-healthy Diet Please Stand Up! current report-Management of Ventricular Arrhythmias in Adults with Congenital Heart Disease current report-